上海药明生物技术有限公司 Wuxi Biologics
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19 2021-03-16 16:30
Remote Pre-Approval Inspection Completed by EMA on WuXi Biologics' MFG4 Facility 2021-03-03 18:23
WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories 2021-02-25 08:00
The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics 2021-02-09 08:25
WuXi Biologics Receives GMP Certification from Brazil's ANVISA 2020-12-28 17:50
WuXi Biologics to Acquire Drug Substance Facility in Wuppertal, Germany from Bayer 2020-12-21 21:02
Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation 2020-12-02 19:00
WuXi Biologics Launched Biologics Integrated Innovation Center in Hangzhou 2020-11-20 16:30
WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa 2020-10-29 17:00
WuXi Biologics Records Excellent Interim Results 2020-08-18 00:51
WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer 2020-08-06 17:00
WuXi Biologics Awarded as "Most Honored Company" by Institutional Investor 2020-08-04 17:00
Embrace Change to Turn Challenges into Opportunities: WuXi Biologics Successfully Hosted the 2nd Investor Day 2020-06-19 17:56
WuXi Biologics (Suzhou) Received EMA GMP Certificate for Biosafety Testing 2020-06-16 08:00
WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States 2020-06-09 08:00
WuXi Biologics Sweeps 2020 CMO Leadership Awards in All Six Categories 2020-05-28 08:00
WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in the United States 2020-05-19 08:00
WuXi Biologics and Aravive Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer and Fibrosis Using the WuXiBody™ Platform 2020-04-30 19:00
WuXi Biologics Successfully Completes PFS Filling at its Robotic Aseptic Filling Facility 2020-04-28 08:00
WuXi Biologics Completed Acquisition of a Drug Product Manufacturing Facility in Germany 2020-04-22 08:00
1 2 3 4 5 6 8